International Clinical Trial: Skin Safety test of CirculumeTM HQ Cream

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109272) titled 'Skin Safety test of CirculumeTM HQ Cream' on April 24.

Study Type: Interventional

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: Hacks & Slacks Healthcare

Intervention: Intervention1: Finn chamber: Each patch contains 0.04g/40 microliter, of 1.CirculumeTM HQ Cream, Route of Administration: Topical Frequency: Once Duration:24hrs Control Intervention1: Finn chamber: 2.Negative control(0.9% NaCl), 3.Positive Control- (1% SLS)

Recruitment Status: Not Recruiting

Phas...